Position in GILD
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$353,246
-$22,495 QoQ
Shares Held
2,796
+3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,563
of 2,266 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLC Capital Advisors holds $21,615,806 across 11 Drug Manufacturers - General names. GILD ranks #9 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
86,579 | $11,125,401 | |
| 2 | JNJ |
Johnson & Johnson
|
13,403 | $3,403,959 | |
| 3 | PFE |
Pfizer Inc
|
66,092 | $1,591,495 | |
| 4 | ABBV |
AbbVie Inc.
|
6,063 | $1,525,693 | |
| 5 | LLY |
ELI LILLY & Co
|
1,111 | $1,332,566 | |
| 6 | AMGN |
Amgen Inc
|
2,086 | $755,382 | |
| 7 | NVS |
Novartis AG
|
3,066 | $480,503 | |
| 8 | NVO |
Novo Nordisk A S
|
9,824 | $470,962 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $353,246 | 2,796 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $375,741 | 2,696 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $331,275 | 2,699 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $299,589 | 2,699 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $299,016 | 2,697 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $302,086 | 2,696 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $249,029 | 2,696 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $226,032 | 2,696 | Shares | Sole | 2024-10-16 | |
| 2024-03-31 | $207,370 | 2,831 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $229,339 | 2,831 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $212,155 | 2,831 | Shares | Sole | 2024-01-18 | |
| 2023-06-30 | $218,185 | 2,831 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $234,888 | 2,831 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $287,683 | 3,351 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $200,862 | 3,256 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $347,743 | 5,626 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $334,465 | 5,626 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $517,418 | 7,126 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $797,617 | 11,419 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $820,742 | 11,919 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $770,324 | 11,919 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $639,053 | 10,969 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $456,168 | 7,219 | Shares | Sole | 2020-10-23 | |
| No filing history on record for this holder in this stock. | ||||||